Skip to content

Effect of dexmedetomidine on the perioperative circulation and postoperative cognitive function of elderly patientsreceiving one-lung ventilation

Effect of dexmedetomidine on the perioperative circulation and postoperative cognitive function of elderly patientsreceiving one-lung ventilation

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-IPR-16009145
Enrollment
Unknown
Registered
2016-09-02
Start date
2016-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative cognitive dysfunction

Interventions

low-dose Dex group:low-dose dexmedetomidine
high-dose Dex group:high-dose dexmedetomidine
control group:normal saline

Sponsors

Department of Anesthesiology, First Affiliated Hospital of Inner Mongolia medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. An informed consent; 2. Patients receiving elective surgery under general anaesthesia with OLV (thoracotomy and thoracoscopy, operation time no more than 6h); 3. American Society of Anaesthesiologists (ASA) grade I-III; 4. Aged 55 to 75 years; 5. BMI 18-25 kg/m2.

Exclusion criteria

Exclusion criteria: 1. Systolic blood pressure =180 mmHg or <90 mmHg, diastolic blood pressure =110 mmHg or <60 mmHg; 2. Serious heart, liver, kidney, lung, endocrine diseases or severe infection; 3. Expected potential or previous difficult airway; 4. A history of abnormal anesthesia; 5. Malignant hyperthermia tendency; 6. Administration of sedatives, antidepressants, or severe alcoholism; 7. Mini Mental State Examination (MMSE) score =17 points; 8. Education level lower than Grade 6 in elementary school; 9. Severe vision disorder, dysaudia or mental instability, mental illness or other conditions that hamper communication; 10. A history of shock; 11. Patients with carotid stenosis or a history of central nervous system diseases, like stroke and epilepsy; 12. Allergic to the study drug or other contraindications; 13. Participation in the clinical study of other drug(s) over the past 30 days.

Design outcomes

Primary

MeasureTime frame
MMSE score;auditory verb learning test , controlled word association test, language continuity test , digital symbol substitution test, trail making test A, trail making test B , shape matching test D, shape matching test ND, self-rating anxiety scale, and self-rating depression scale;

Secondary

MeasureTime frame
pulse, oxygen saturation of blood,heart rate (HR), systolic blood pressure, diastolic blood pressure, end-tidal carbon dioxide partial pressure (PETCO2), airway pressure and blood gas analysis;perioperative blood transfusion amount, fluid intake and output, the overall operation time, OLV time, two-lung ventilation time, intraoperative drug dosage and dosage of analgesics used for postoperative pain management;

Countries

China

Contacts

Public ContactYaying Xie

First Affiliated Hospital of Inner Mongolia medical university

912930621@163.com+86 15804712756

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026